American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

  • Take Action to Protect Medical Research

    In July, the Senate Appropriations Committee approved a draft spending bill that would provide nearly $31 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2014, an amount that would replace funding lost due to sequestration and provide a small increase over the FY 2012 NIH budget.

  • Urge Congress to Pass the SGR Repeal and Medicare Provider Payment Modernization Act and Provide Stable Medicare Physician Payments

    On February 6, 2014 the leadership of the House Ways and Means and Energy and Commerce Committees and the Senate Finance Committee released a bi-partisan and bicameral bill to repeal the Sustainable Growth Rate (SGR) formula that has driven annual reductions in Medicare payment for physician services. Your advocacy is needed to ensure that the legislation can be considered by the full House of Representatives and Senate before the short-term physician fee update expires on April 1, 2014.

  • Urge Your Representative to Cosponsor the Cancer Drug Coverage Parity Act

    Legislation has been introduced in the U.S. House of Representatives and U.S. Senate that would ensure that patients enrolled in certain federally regulated health plans have access and insurance coverage for all anti-cancer regimens.

View all action alerts
  • Summary of 2015 Medicare Physician Fee Schedule Proposed Rule

    The 2015 Medicare Physician Fee Schedule proposed rule proposes payment rates and related policies.  The ASH summary focuses on issues of interest to hematologists, including potential future payment changes to chemotherapy, changes to the ASH performance measures used in PQRS, and changes to way local coverage determinations are made for laboratory tests.

  • ASH Committee on Practice Visits Congress to Discuss Access to Specialty Tier Drugs and Medicare Payment

    Following its May 19 meeting in Washington, DC, the ASH Committee on Practice visited more than thirty congressional offices to advocate for patient access to affordable drugs, as well as for repeal of the current Sustainable Growth Rate (SGR) formula and reform of Medicare payment for physician services.

  • NIH Announces Updated Policy for Application Submission

    The National Institutes of Health (NIH) yesterday announced that its resubmission policy has changed. Effective immediately, researchers whose grant applications are unsuccessful may submit the same idea as a new and unassociated application for the next appropriate due date.

  • ASH Committee on Government Affairs Visits Congress to Discuss Research Funding and Oral Chemotherapy Parity

    Following its April 8 meeting in Washington, DC, the ASH Committee on Government Affairs visited nearly 40 congressional offices on April 9 to explain to Members of Congress and their staff the impact that cuts in funding to the National Institutes of Health (NIH) has on research to find cures and treatments for patients with serious hematologic diseases and the need to continue to support and invest in federal biomedical research funding.

View all policy news
back to top